HCV persistence: Cure is still a four letter word

被引:21
作者
Feld, JJ [1 ]
Liang, TJ [1 ]
机构
[1] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1002/hep.20561
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:23 / 25
页数:3
相关论文
共 23 条
[1]   The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 [J].
Alter, MJ ;
Kruszon-Moran, D ;
Nainan, OV ;
McQuillan, GM ;
Gao, FX ;
Moyer, LA ;
Kaslow, RA ;
Margolis, HS .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (08) :556-562
[2]   Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease [J].
Cacciola, I ;
Pollicino, T ;
Squadrito, G ;
Cerenzia, G ;
Orlando, ME ;
Raimondo, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (01) :22-26
[3]   Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown [J].
Castillo, I ;
Pardo, M ;
Bartolomé, J ;
Ortiz-Movilla, N ;
Rodríguez-Iñigo, E ;
de Lucas, S ;
Salas, C ;
Jiménez-Heffernan, JA ;
Pérez-Mota, A ;
Graus, J ;
López-Alcorocho, JM ;
Carreño, V .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (01) :7-14
[4]   Occult HBV infection in cryptogenic liver cirrhosis in an area with high prevalence of HBV infection [J].
Chan, HLY ;
Tsang, SWC ;
Leung, NWY ;
Tse, CH ;
Hui, Y ;
Tam, JSL ;
Chan, FKL ;
Sung, JJY .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (05) :1211-1215
[5]   Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes [J].
Ducoulombier, D ;
Roque-Afonso, AM ;
Di Liberto, G ;
Penin, F ;
Kara, R ;
Richard, Y ;
Dussaix, E ;
Féray, C .
HEPATOLOGY, 2004, 39 (03) :817-825
[6]   Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C [J].
Fabris, P ;
Brown, D ;
Tositti, G ;
Bozzola, L ;
Giordani, MT ;
Bevilacqua, P ;
de Lalla, F ;
Webster, GJM ;
Dusheiko, G .
JOURNAL OF CLINICAL VIROLOGY, 2004, 29 (03) :160-166
[7]   Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation [J].
Forns, X ;
García-Retortillo, M ;
Serrano, T ;
Feliu, A ;
Suarez, F ;
de la Mata, M ;
García-Valdecasas, JC ;
Navasa, M ;
Rimola, A ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2003, 39 (03) :389-396
[8]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982
[9]   Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C [J].
Kao, JH ;
Chen, PJ ;
Lai, MY ;
Chen, DS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4068-4071
[10]   Long-term clinical impact of occult hepatitis B virus infection in chronic hepatitis B patients [J].
Komori, M ;
Yuki, N ;
Nagaoka, T ;
Yamashiro, M ;
Mochizuki, K ;
Kaneko, A ;
Yamamoto, K ;
Hikiji, K ;
Kato, M .
JOURNAL OF HEPATOLOGY, 2001, 35 (06) :798-804